|
(E/Z)-Doxepin Glucuronide
|
DOXEPIN GLUCURONIDE (MIXTURE OF Z AND E ISOMERS)
|
788790-52-3
|
|
N-Desmethyl Doxepin HCl
|
N-去甲鹽酸多塞平
|
2887-91-4
|
|
(Z)-Doxepin HCl
|
多塞平EP雜質(zhì)D
|
25127-31-5
|
|
1’-epi-Entecavir
|
|
|
|
Febuxostat Impurity 5
|
2-(3-氰基-4-羥基苯基)-4-甲基-1,3-噻唑-5-羧酸乙酯
|
161798-02-3
|
|
Trelagliptin Impurity 10
|
曲格列汀雜質(zhì)10
|
|
|
Febuxostat Impurity 11
|
4-硝基鄰苯二甲腈
|
31643-49-9
|
|
Febuxostat Impurity 16
|
Febuxostat Impurity 16
|
2473435-22-0
|
|
Vortioxetine Sulfoxide
|
|
|
|
Ibrutinib Impurity 4
|
伊布替尼雜質(zhì)4
|
1807619-68-6
|
|
Vortioxetine Impurity 24
|
沃替西汀雜質(zhì)24
|
|
|
Enzalutamide Impurity C
|
2-氟-4-溴苯甲酸甲酯
|
179232-29-2
|
|
Ibrutinib Impurity 8
|
伊布替尼中間體N-2
|
330786-24-8
|
|
Ibrutinib Impurity 3
|
Ibrutinib Impurity 3
|
1226872-27-0
|
|
Febuxostat Impurity (2,2'-(4-isobutoxy-1,3-phenylene)bis(4-methylthiazole-5-carboxylic acid))
|
非布索坦雜質(zhì)9
|
1330632-48-8
|
|
Enzalutamide Impurity 2
|
4-異硫代氰酰基-2-(三氟甲基)苯甲腈
|
143782-23-4
|
|
Febuxostat Impurity 18
|
|
|
|
Febuxostat Impurity 19
|
非布索坦中間體雜質(zhì)
|
118485-48-6
|
|
Febuxostat Impurity 3
|
非布索坦中間體
|
160844-75-7
|
|
Afatinib Impurity 2
|
阿法替尼雜質(zhì)46
|
1449430-45-8
|
|
Trelagliptin Impurity 13
|
曲格列汀雜質(zhì) 9
|
|
|
Trelagliptin Impurity 7
|
曲格列汀雜質(zhì)7
|
|
|
Trelagliptin Impurity 9
|
曲格列汀雜質(zhì) 8
|
|
|
Trelagliptin Impurity 16
|
曲格列汀雜質(zhì)16
|
|
|
Febuxostat Impurity 7
|
非布司他雜質(zhì)7
|
1350352-70-3
|
|
Febuxostat Impurity (4-Isobutoxy benzene-1,3-bis(carbothio amide))
|
非布索坦雜質(zhì)O
|
1330632-46-6
|
|
Febuxostat Impurity 2
|
2-(3-醛基-4-異丁氧基苯基)-4-甲基噻唑-5-甲酸乙酯
|
161798-03-4
|
|
4-Hydroxy Propranolol Sulfate Potassium Salt
|
4-Hydroxy Propranolol Sulfate Potassium Salt
|
1261395-42-9
|
|
Trelagliptin Impurity 6
|
曲格列汀雜質(zhì)6
|
|
|
Febuxostat Impurity (2-(3-carboxy-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid)
|
非布索坦雜質(zhì)B
|
1239233-87-4
|
|
Trelagliptin Impurity 15
|
曲格列汀雜質(zhì)15
|
|
|
2-Hydroxy Propranolol HCl
|
2-羥基普萘洛爾鹽酸鹽
|
76275-62-2
|
|
Trelagliptin Impurity 4
|
曲格列汀雜質(zhì)4
|
|
|
Febuxostat Impurity 9
|
非布索坦雜質(zhì)T
|
407582-48-3
|
|
(S)-Ibrutinib
|
（S）-依魯替尼
|
936563-97-2
|
|
Febuxostat Impurity 15
|
|
|
|
Febuxostat Impurity 12
|
Febuxostat Impurity 12
|
|
|
4-Bromo-2-fluorobenzoic acid
|
4-溴-2-氟苯甲酸
|
112704-79-7
|
|
Febuxostat Impurity 1
|
2-(3-醛基-4-羥基苯基)-4-甲基噻唑-5-羧酸乙酯
|
161798-01-2
|
|
Febuxostat Impurity 10
|
Febuxostat Impurity 10
|
|
|
Febuxostat Impurity 14
|
非布索坦雜質(zhì)14
|
1335202-60-2
|
|
Febuxostat Impurity 17
|
2-(3-氨甲酰基-4-羥基)苯基-4-甲基噻唑-5-甲酸乙酯
|
|
|
Vortioxetine Impurity 9 HCl
|
沃替西汀雜質(zhì)9
|
|
|
Trelagliptin Impurity 5
|
曲格列汀雜質(zhì)
|
77532-85-5
|
|
Trelagliptin Impurity 11
|
曲格列汀雜質(zhì)11
|
|
|
5-Hydroxy Propranolol Glucuronide (Mixture of Diastereomers)
|
5-羥基普萘洛爾葡糖醛酸(非對(duì)映異構(gòu)體混合物)
|
127182-49-4
|
|
Trelagliptin Impurity 14
|
1-甲基巴比妥酸
|
2565-47-1
|
|
Febuxostat Impurity (Dimethyl 2,2'-(4-isobutoxy-1,3-phenylene)bis(4-methylthiazole-5-carboxylate))
|
非布司他雜質(zhì)C
|
1330632-47-7
|
|
Trelagliptin Impurity 12
|
曲格列汀雜質(zhì)12
|
|
|
Trelagliptin Impurity 3
|
曲格列汀雜質(zhì) 3
|
|
|
Febuxostat Impurity 6
|
非布司他雜質(zhì)6
|
1271738-74-9
|
|
Febuxostat Impurity 8
|
Febuxostat Impurity 8
|
144060-62-8
|
|
Afatinib Impurity 5
|
N-(3-氯-4-氟苯基)-7-甲氧基-6-硝基喹唑啉-4-胺
|
179552-74-0
|
|
Afatinib Impurity A
|
4-【(3-氯-4-氟苯基)氨基】-6-硝基-7-【(R)-四氫呋喃-4-基氧基】-喹唑啉
|
402855-07-6
|
|
Trelagliptin Impurity 2
|
曲格列汀雜質(zhì)2
|
|
|
Trelagliptin Impurity 8
|
曲格列汀雜質(zhì) 1
|
|
|
Ibrutinib Impurity 5
|
伊布替尼雜質(zhì)5
|
|
|
Vortioxetine Impurity 8
|
沃替西汀雜質(zhì)8
|
|
|
Ibrutinib Impurity 6
|
伊布替尼雜質(zhì)6
|
1917333-91-5
|
|
Ibrutinib Impurity 2
|
依魯替尼雜質(zhì)2
|
|
|
Febuxostat Impurity 13
|
Febuxostat Impurity 13
|
|
|
Posaconazole Impurity 34 Oxalate
|
|
|
|
Posaconazole Impurity 25 Oxalate
|
|
|
|
rac-Posaconazole Diastereoisomer Related Compound 3
|
RAC-泊沙康唑非對(duì)映異構(gòu)體相關(guān)化合物3
|
|
|
Posaconazole Diastereoisomer Related Compound 8
|
(5R-CIS)-甲苯-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氫呋喃-3-基甲基酯
|
149809-43-8
|
|
Posaconazole Impurity 32 Oxalate
|
|
|
|
Posaconazole Impurity 23 Dihydrochloride
|
|
|
|
Posaconazole Impurity 35 Oxalate
|
泊沙康唑雜質(zhì)35(草酸鹽)
|
|
|
N-Hydroxylated Vortioxetine Glucuronide
|
N-羥基化沃替西汀葡糖醛酸
|
|
|
Vortioxetine Impurity 13
|
1-(2-溴苯基)哌嗪
|
1011-13-8
|
|
Vortioxetine Impurity 18
|
DISULFIDE, BIS(2,4-DIMETHYLPHENYL)
|
13616-83-6
|
|
Vortioxetine Impurity 16
|
2,4-二甲基苯基苯硫醚
|
16704-47-5
|
|
Vortioxetine Impurity 10 HCl
|
沃替西汀雜質(zhì)10
|
|
|
Vortioxetine Impurity 17
|
Vortioxetine Impurity 17
|
2368241-98-7
|
|
Vortioxetine Impurity 5
|
沃替西汀雜質(zhì)5
|
|
|
Vortioxetine Impurity 26
|
沃替西汀雜質(zhì)26
|
|
|
Vortioxetine Impurity 11
|
沃替西汀雜質(zhì)11
|
|
|
Vortioxetine Impurity 21
|
沃替西汀雜質(zhì)21
|
|
|
Vortioxetine Impurity 15
|
Vortioxetine Impurity 15
|
2099147-02-9
|
|
Vortioxetine Impurity 7
|
沃替西汀雜質(zhì)7
|
|
|
Vortioxetine Impurity 12
|
沃替西汀雜質(zhì)12
|
|
|
Vortioxetine Impurity 25
|
|
|
|
Vortioxetine Impurity 22
|
沃替西汀雜質(zhì)22
|
|
|
Doxepin related compound C
|
多塞平雜質(zhì)C
|
4504-96-5
|
|
Propranolol N-Formyl Impurity
|
|
77252-67-0
|
|
Capecitabine Impurity 3 (Defluoro Capecitabine)
|
Capecitabine Impurity 3
(Defluoro Capecitabine)
|
216450-02-1
|
|
(E)-Doxepin HCl
|
(E)-Doxepin hydrochloride
|
4698-39-9
|
|
Doxepin EP Impurity B
|
11-[3-(二甲胺基)丙基]-6,11-二氫二BENZ[B,E]氧雜環(huán)庚烷-11-醇
|
4504-88-5
|
|
Nifuratel Impurity B
|
硝呋太爾雜質(zhì)B
|
736-53-8
|
|
Doxepin related compound A
|
6,11-二氫二苯并[b,e]氧雜卓-11-酮
|
4504-87-4
|
|
Doxepin
|
多慮平
|
1668-19-5
|
|
rac Propranolol β-D-Glucuronide Sodium Salt
|
RAC PROPRANOLOL Β-D-GLUCURONIDE SODIUM SALT
|
|
|
5-Hydroxy Propranolol HCl
|
5-羥基普萘洛爾鹽酸鹽
|
62117-35-5
|
|
7-Hydroxy Propranolol Glucuronide (Mixture of Diastereomers)
|
(+/-)-7-羥基普萘洛爾葡糖苷酸
|
1418018-59-3
|
|
7-Hydroxy Propranolol HCl
|
7-羥基普萘洛爾鹽酸鹽
|
76275-67-7
|
|
Propranolol N-Acetyl Impurity
|
N-[2-羥基-3-(1-萘氧基)丙基】-N-(1-甲基乙基)甲酰胺
|
2007-11-6
|
|
Propranolol Impurity B
|
普萘洛爾雜質(zhì)B
|
83314-78-7
|
|
Propranolol Impurity A, diol derivative
|
3-(萘酚基)-1,2-二羥基丙烷
|
36112-95-5
|
|
rac-4-Hydroxy Propranolol HCl
|
4-羥基普萘洛爾鹽酸鹽
|
14133-90-5
|
|
Propranolol impurity C, bis-ether derivative
|
1,3-二(萘-1-基氧基)丙-2-醇
|
17216-10-3
|